-
Zelensky slams his security services for 'unacceptable' shootout
-
Looming far-right win in Germany sparks security worries
-
Farage's Reform UK meets as new donation scandal hits
-
Tanker captain arrested over cargo ship sinking off Istanbul
-
Volunteers fight uphill battle against Indonesian fires
-
India hopes 'unique idea' will save athletes from cabin fever
-
PU Prime Launches Australian Operations under ASIC Licence
-
UK asserts 'unshakeable' Falklands commitment after Milei presses claim
-
Night-owl Zverev goes distance to advance as upsets rock US Open
-
How a Dostoevsky novella took TikTok by storm
-
Marathon man Zverev goes distance again to reach US Open third round
-
Zverev goes the distance again to reach US Open third round
-
US study tests psilocybin to fight cancer side effects
-
German AfD's love for Simson mopeds dismays Jewish family behind brand
-
Italy's Meloni throws party to celebrate record in power
-
Two trapped tunnel workers rescued in Nepal 'miracle'
-
After heatwaves, will EU pivot back to the climate fight?
-
Ex-Pakistan coach Gillespie tells Javed 'look in the mirror' over sackings
-
South Korean football referee faces hearing over 'period' insult
-
Monfils falls to Tien in US Open in Grand Slam farewell
-
Toulouse eye Top 14 history after 'difficult' summer
-
Arsenal brace for Chelsea test as Spurs seek spark
-
Springboks and All Blacks seek series lead after war of words
-
Efficient Rybakina reaches US Open third round
-
Bundesliga brings the band back together in Premier League's shadow
-
Taiwan boxer Lin considered 'graceful exit' after Paris Games gold
-
Asian stocks rally as traders pare rate bets ahead of jobs data
-
'I miss my home': Cambodians displaced by conflict start over
-
War-bruised Myanmar finds relief in bareknuckle bloodsport
-
Ailing Auger-Aliassime falls at US Open as Swiatek, Osaka and Gauff advance
-
Gauff downs Badosa to reach US Open third round
-
Tesla launches self-driving 'Cybercab' in Texas
-
New Zealand approves use of party drug MDMA to treat trauma
-
'Wallace & Gromit' creators turn 50 with spook-tacular Shaun yarn
-
Westerners test their mettle at World Nomad Games in Kyrgyzstan
-
New York's Muslims reclaim their city after 9/11 backlash
-
Gauff cruises into US Open third round
-
Premier League transfer windfall a lifeline for ailing French clubs
-
Kyrgios gets month ban for cocaine, enters treatment programme
-
Chile protesters see shades of Pinochet in new security plan
-
AELF Expands Global Commercial Team
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 04
-
Colombian judge bans strikes on guerrillas if minors are present
-
Carreras reverts to fullback as Argentina change four for Australia Test
-
Khachanov shocks ailing Auger-Aliassime, Swiatek and Osaka advance at US Open
-
Wilson back to lead Australia as Kiss rotates team for Argentina
-
Lone juror blocking verdict in US mother's child murder trial: defense
-
Yen surges on new intervention talk, US stocks rally
-
'Kinda chic' - Williams sisters set to launch US Open doubles bid
-
Japan's Ueda fires Lille top of Ligue 1 on debut
Biometric Identification and Cybersecurity Software Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference at 11:30am ET, Jan. 28 in Atlantic City, NJ
ATLANTIC CITY & HOLMDEL, NJ / ACCESS Newswire / January 13, 2026 / BIO-key® International, Inc. (NASDAQ:BKYI), a leading provider of biometric enabled Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless, and phish-resistant authentication, will participate at the DealFlow Discovery Conference Wednesday and Thursday, January 28th and 29th at the Borgata hotel in Atlantic City, New Jersey. Institutional investors, family offices and high-net-worth investors are invited to attend at no cost.
BIO-key CEO Mike DePasquale will present on Wednesday at 11:30 am ET in Room 1 and will be available for 1-on-1 meetings throughout the event. BIO-key's presentation details will be posted on DealFlow's website in January.
Registration:
Click here: https://dealflowdiscoveryconference.com/registration/ to register for the Discovery Conference.
About The DealFlow Discovery (www.dealflowdiscoveryconference.com)
The DealFlow Discovery Conference is where high-growth companies come to be discovered. Formerly known as The Microcap Conference, the event has been expanded to include both publicly traded microcaps and qualified private companies across a variety of high-growth sectors.
Organized by DealFlow Events, the conference brings together hundreds of companies, investors, and dealmakers for two days of company presentations, expert discussions on raising capital, unlimited 1-on-1 meetings, interactive sessions and networking opportunities. The Discovery Conference delivers a high visibility platform for companies to showcase their value propositions to a broad base of prospective investors.
Keynote presentations and panel discussions led by renowned industry figures will provide insights on business, investing, entrepreneurial success, and other trends in US equity markets, from capital formation to regulatory updates, tailored to the public microcap and private market communities.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Engage with BIO-key:
LinkedIn - Corporate: https://www.linkedin.com/company/bio-key-international
X - Corporate: @BIOkeyIntl
X - Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts:
William Jones, David Collins
Catalyst IR
[email protected] or 212-924-9800
SOURCE: DealFlow Events
View the original press release on ACCESS Newswire
F.Bennett--AMWN